- Report
- February 2021
- 500 Pages
United States
From €2311EUR$2,400USD£1,988GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3467EUR$3,600USD£2,982GBP
- Report
- October 2019
- 125 Pages
Canada
From €4574EUR$4,750USD£3,934GBP
- Report
- November 2018
- 30 Pages
China
From €2119EUR$2,200USD£1,822GBP
Amaryl is a drug used to treat type 2 diabetes, a condition in which the body does not produce or use insulin properly. It belongs to a class of drugs known as sulfonylureas, which work by stimulating the pancreas to produce more insulin. Amaryl is used in combination with diet and exercise to help control blood sugar levels. It is also used to reduce the risk of cardiovascular disease in people with type 2 diabetes.
Amaryl is part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. These drugs are used to treat conditions such as diabetes, thyroid disorders, obesity, and osteoporosis. They are also used to treat conditions such as growth hormone deficiency, adrenal insufficiency, and Cushing's syndrome.
Companies in the Amaryl market include Sanofi, Novo Nordisk, Merck, and Eli Lilly. Show Less Read more